SGTX
Morgan Stanley’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-6,418
| Closed | -$144K | – | 7858 |
|
|
2023
Q2 | $144K | Sell |
6,418
-240,411
| -97% | -$5.41M | ﹤0.01% | 5787 |
|
|
2023
Q1 | $230K | Buy |
246,829
+216,685
| +719% | +$202K | ﹤0.01% | 5650 |
|
|
2022
Q4 | $10.6K | Buy |
30,144
+790
| +3% | +$277 | ﹤0.01% | 6914 |
|
|
2022
Q3 | $15K | Sell |
29,354
-12,592
| -30% | -$6.44K | ﹤0.01% | 6937 |
|
|
2022
Q2 | $35K | Sell |
41,946
-14,018
| -25% | -$11.7K | ﹤0.01% | 6780 |
|
|
2022
Q1 | $82K | Sell |
55,964
-340,033
| -86% | -$498K | ﹤0.01% | 6449 |
|
|
2021
Q4 | $1.09M | Sell |
395,997
-110,320
| -22% | -$304K | ﹤0.01% | 5008 |
|
|
2021
Q3 | $2.86M | Sell |
506,317
-40,625
| -7% | -$229K | ﹤0.01% | 4276 |
|
|
2021
Q2 | $5.87M | Buy |
546,942
+544,909
| +26,803% | +$5.85M | ﹤0.01% | 3619 |
|
|
2021
Q1 | $45K | Sell |
2,033
-1,199
| -37% | -$26.5K | ﹤0.01% | 6398 |
|
|
2020
Q4 | $155K | Buy |
+3,232
| New | +$155K | ﹤0.01% | 5721 |
|